 |
Vaccine Seminar: Vaccines in
the 21st Century
Organized by: Sondra Schlesinger, Washington
University; Raymond E. Spier, University of Surrey,
United Kingdom; Mary Estes, Baylor College of Medicine;
JoAnn M. Valenti, Brigham Young University; King K.
Holmes, University of Washington
Friday, 13 February
3:00PM–6:00PM
Saturday, 14 February
9:00AM–6:00PM
Sponsored by the Gates Foundation
Two of the most important contributions of biomedical
science to public health in the 20th century were the
eradication of smallpox and the almost complete elimination
of poliomyelitis through vaccines. At the beginning
of the 21st century, there is hope that vaccines can
be developed against some other major diseases including
non-infectious diseases such as cancer. But along with
this potential, vaccination is also becoming more controversial.
How can vaccines be distributed effectively to developing
countries? Why has it not been possible to develop an
effective vaccine against AIDS? Against malaria? Are
there side effects of vaccination which can lead to
other illnesses? Vaccines have been so effective against
infectious diseases that, in the western hemisphere,
the public has little memory of the devastating effects
of diseases such as polio or measles. The incredible
successes of vaccination against infectious diseases
in the developed world will be discussed, but also contrasted
with the continued presence of these diseases in the
developing world and with the perception in many developed
countries that vaccines are not safe and pose a threat.
|
FRIDAY • 13 February 2004
|
| 3:00PM–6:00PM |
Vaccines in the 21st Century: Progress and
Problems
• Margaret A. Liu, Transgene
Gene-Based Vaccines and Immunotherapies for
Infectious Diseases and Cancer
• Olen Kew, U.S. Centers for Disease Control
and Prevention
Global Polio Eradication: Current Progress
and Future Challenges
• Louis H. Miller, National Institutes of
Health
Why Malaria Vaccine Development is an Important
Investment: Need and Feasibility
• Laura Koutsky, University of Washington
Prophylactic HPV Vaccines: What We Know and
What We Should Expect
• Harry B. Greenberg, Stanford University
Medical Center
Live Intranasal Influenza Vaccine: A New Era
Begins
• Raj Shah, Gates Foundation
The Introduction and Adoption of New Technologies
in Resource-Poor Settings
|
| |
|
|
SATURDAY • 14 February
2004
|
| 9:00AM–NOON |
Public Perception of Vaccination Risks
• Lisa Davis
On the Attitudes of Concerned Parents to Vaccination
• Raymond E. Spier, University of Surrey,
United Kingdom
Antivaccine Movements in History: Lessons to
be Learned
• Paul A. Offit, The Children’s Hospital
of Philadelphia
Getting Fully Informed About Vaccines
• Ann Bostrom, Georgia Institute of Technology
Risk Perception and Vaccination Acceptability
• Robert T. Chen, U.S. Centers for Disease
Control and Prevention
How Data on Vaccine Safety May be Deployed
to Change Attitudes
• Daniel Salmon, Johns Hopkins Bloomberg
School of Public Health
Parental Beliefs Associated with Claiming Non-Medical
Exemptions to School Immunization Requirements
|
| |
 |
| 3:00PM–6:00PM |
The HIV/AIDS Epidemic: Challenges and Hope
Speakers:
• Stephen Lewis, United Nations Special Envoy
for HIV/AIDS in Africa
Why Must the AIDS Epidemic be Fought on All
Fronts?
• Robert M. Grant, Gladstone/University
of California, San Francisco
Are Drugs for AIDS Winning the Battle Against
the Virus?
• Larry Corey, Fred Hutchinson Cancer Center
HIV Vaccine Research: The State of the Science
• Tom Coates, University of California,
San Francisco
Prevention of HIV Transmission Focusing on
the Infected: What to Do?
• Helene Gayle, Bill and Melinda Gates Foundation,
Global Health Program
Dealing with the AIDS Epidemic in Developing
Countries
|
| • BACK
TO TOP |
|
|
